Holen Sie sich die Stockscreener-App
1.11
0.91%
0.01
Schlusskurs vom Vortag:
$1.10
Offen:
$1.08
24-Stunden-Volumen:
15,387
Relative Volume:
0.04
Marktkapitalisierung:
$17.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-0.8409
EPS:
-1.32
Netto-Cashflow:
$-8.02M
1W Leistung:
+3.74%
1M Leistung:
-6.72%
6M Leistung:
-22.38%
1J Leistung:
-41.58%
1-Tages-Spanne:
$1.08
$1.11
1-Wochen-Bereich:
$1.025
$1.11
52-Wochen-Spanne:
$0.6554
$2.45
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Firmenname
Hoth Therapeutics Inc
Sektor
Branche
Telefon
(646)756-2997
Adresse
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Vergleichen Sie HOTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.11 | 17.07M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.37 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.29 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
814.78 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.34 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-15 | Eingeleitet | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Why Hoth Therapeutics Inc. stock remains resilient2025 Momentum Check & Free Long-Term Investment Growth Plans - ulpravda.ru
Growth Value: Is Hoth Therapeutics Inc. stock supported by innovation pipelineEarnings Growth Report & Risk Managed Investment Signals - ulpravda.ru
Can Hoth Therapeutics Inc. stock weather global recessionWeekly Stock Report & Risk Controlled Daily Plans - ulpravda.ru
Will Hoth Therapeutics Inc. stock beat EPS estimatesJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - ulpravda.ru
Big Money Moves: Why Hoth Therapeutics Inc. stock could outperform in 2025Trade Analysis Summary & Fast Momentum Stock Entry Tips - ulpravda.ru
Why Hoth Therapeutics Inc. stock could outperform in 2025Quarterly Performance Summary & Detailed Earnings Play Alerts - ulpravda.ru
Hoth Therapeutics Files Dual U.S. Provisional Patents to Expand Oncology Dermatology IP - Digital Health News
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform - Nasdaq
Hoth Therapeutics Files Two US Provisional Patents for Oncology-Focused Dermatology Platform; Shares Rise - MarketScreener
Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform - Contract Pharma
Hoth therapeutics files patents for oncology skin toxicity treatments By Investing.com - Investing.com Canada
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments - Investing.com Nigeria
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments By Investing.com - Investing.com South Africa
New patents target painful skin side effects from modern cancer treatments - Stock Titan
Hoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s Excited - MSN
Hoth Therapeutics (NASDAQ:HOTH) Stock Price Down 2.9% – Here’s What Happened - Defense World
Why Hoth Therapeutics Inc. stock remains undervaluedTrade Signal Summary & Precise Buy Zone Identification - DonanımHaber
Is Hoth Therapeutics Inc. stock trading near support levelsJuly 2025 Retail & Weekly Return Optimization Alerts - Улправда
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Aug Highlights: Is Hoth Therapeutics Inc stock gaining market shareWeekly Profit Report & Long-Term Capital Growth Strategies - moha.gov.vn
Sentiment Review: Why Hoth Therapeutics Inc stock remains undervaluedJuly 2025 EndofMonth & Safe Entry Zone Tips - moha.gov.vn
Published on: 2025-12-10 00:57:10 - moha.gov.vn
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal - ts2.tech
Hoth Therapeutics (HOTH) Price Target Increased by 12.50% to 4.59 - Nasdaq
D. Boral Capital Maintains Hoth Therapeutics (HOTH) Buy Recommendation - Nasdaq
Hoth Therapeutics stock rises after pipeline update By Investing.com - Investing.com India
Hoth Therapeutics stock rises after pipeline update - Investing.com
Hoth Therapeutics, Inc. Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated Ht-Kit, Advancing Ht-001 Phase 2, and New Gdnf Metabolic Program - MarketScreener
Hoth Therapeutics advances pipeline with four clinical programs By Investing.com - Investing.com India
Hoth Therapeutics advances pipeline with four clinical programs - Investing.com
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program - PR Newswire
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 - Eastern Progress
Bearish Setup: Is Hoth Therapeutics Inc. stock trading near support levelsQuarterly Risk Review & Real-Time Volume Analysis Alerts - moha.gov.vn
Wall Street analysts’ outlook for Hoth Therapeutics Inc (HOTH) - Setenews
What technical signals suggest for Hoth Therapeutics Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research By Investing.com - Investing.com Nigeria
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research - Investing.com
Hoth Therapeutics accepted into Nvidia Connect Program, expanding its AI and accelerated computing capabilities - MarketScreener
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities - PR Newswire
Can Hoth Therapeutics Inc. stock deliver surprise earnings beat2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
Can Hoth Therapeutics Inc. stock maintain growth trajectoryQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Is Hoth Therapeutics Inc a good long term investmentVolume Weighted Average Price & Free Superior Profit Margins - earlytimes.in
Can Hoth Therapeutics Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
What moving averages say about Hoth Therapeutics Inc.Earnings Beat & Target Return Focused Picks - newser.com
Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):